LFL2019_ohjelmakansi_1920x470px
15.05

16.05
2019

Life Science Live 2019

Life Science Live is a new international event for professionals in the fields of pharmaceuticals and healthcare. The event will take place at the Turku Fair and Congress Center on May 15–16, 2019.

The science content at Life Science Live will be coordinated by the University of Turku, Åbo Akademi University, Turku University of Applied Sciences and Turku Science Park Ltd (HealthTurku). The HealthBio event by Turku Science Park Ltd. is organized simultaneously with Life Science Live. In connection with Life Science Live a two-day-long i-HD (Improved Health Data) conference will also take place.

This momentous event will bring international experts in the field to Turku. The participants will include companies, professionals, researchers, students, buyers and investors. The exhibition stands at the event will present the latest innovations. The main theme for the 2019 event will be artificial intelligence and its application in, for instance, healthcare, pharmaceutical development and biotechnology.

− In biomedicine and medicine, the path from basic research to application is getting increasingly shorter. Turku’s universities have strong traditions in developing both pharmaceuticals and diagnostic methods. We are constantly on the lookout for new Finnish and foreign partnerships that will, through more intensive collaboration, lead to health innovations with a global impact. We believe that new forms of interdisciplinary collaboration are the best way to achieve this in future, says Kalervo Väänänen, Rector of the University of Turku.

About the Life Science Live program:

Esiintyjät

Dipak Kalra, PhD, FRCGP, FBCS, is President of the European Institute for Innovation through Health Data. He plays a leading international role in research and development of electronic health record interoperability standards, data and privacy protection, interoperability business models and the reuse of EHRs for research. He has led multiple European projects in these areas, including Horizon 2020 and the IMI programme alongside pharma companies, hospitals and ICT companies.

Laura Elo, PhD, is Research Director  in Bioinformatics and Group Leader in Computational Biomedicine at Turku Centre for Biotechnology (University of Turku and Åbo Akademi University). Her multidisciplinary research group of more than 30 specialists develops computational tools and mathematical modelling methods for analyzing and interpreting data generated by modern high-throughput biotechnologies in a number of national and international research projects (e.g. Horizon 2020 and European Research Council ERC). The ultimate goal is to improve the diagnosis and treatment of complex diseases, such as diabetes and cancer.

Dr. Gabbouj is a Professor of Signal Processing at the Department of Signal Processing, Tampere University of Technology, Tampere, Finland, where he leads the Multimedia Research Group. Dr. Gabbouj is a Fellow of the IEEE, a member of the European Academy and the Finnish Academy of Science and Letters.

Professor Olli Raitakari is currently the Professor in Cardiovascular Medicine, Director of the Turku University Research Centre of Applied and Preventive Cardiovascular Medicine. He is coordinating two large Finnish studies into cardiovascular risk. In addition, he is currently the Principal Investigator of the STRIP Study housed at the University of Turku. Professor Raitakari has introduced the vascular epidemiology, the genetic epidemiology and the population metabolonomics approaches in these studies. His work has allowed the development, modification and validation of the techniques involved in the measurement of subclinical atherosclerotic changes in the vasculature. The techniques have included work on heart and arterial structure/function using a variety of non-invasive imaging methods. The research has contributed to the understanding of pre-clinical development of atherosclerosis in children and young adults, including the effects of diet, life-style, psychological traits, metabolic risk factors, inflammation, hormones and genetic markers.

Teemu Suna is the CEO and one of the founders of Nightingale Health Ltd, a Finnish biotech company reinventing global healthcare for chronic diseases. Standing at the helm of a major success story in the Finnish startup community, Suna has transformed Nightingale into an established growth company with over 60 employees in less than four years. Suna has over 15 years of experience in engineering and management positions, having previously served as Chief Technology Officer at Fujitsu Finland. As a passionate advocate for visionary healthcare solutions, Suna leads Nightingale on its mission to solve the global burden of chronic diseases, empowering people to follow-up on their own health and take actions to stay healthy. Under Suna’s leadership, Nightingale has raised more than 20M€ in funding since Sept 2015.

Karen Madden,  Vice President, Technology & Innovation, PerkinElmer Inc.

Members of the program committee

Jyrki Heino – Professor, Director, Department of Biochemistry, University of Turku, Chairman of the committee
Sari Mäkelä – Professor, Director, Institute of Biomedicine, University of Turku
Pasi Liljeberg – Professor, Department of Future Technologies, University of Turku
Tero Piispanen – Director, Internationalisation Services and BioTurku, Turku Science Park Ltd.
Merja Tieaho – Senior Advisor, Turku Science Park Ltd.
Tero Karhi – Senior Advisor, Turku Science Park Ltd.
Saara Hassinen – CEO, Healthtech Finland
Arto Maaninen – Vice Rector, University of Oulu
Juhani Soini – Vice Rector, Turku University of Applied Sciences
Niklas Sandler – Professor, Vice Rector, Åbo Akademi University
Timo Vasankari – Project Chief, Department of Future Technologies, University of Turku
Tuomas Valtonen – Research Manager, Department of Future Technologies, University of Turku
Juuso Blomster – Chief Physician, Turku University Hospital
Mia Bengström – Senior advisor, Pharma Industry Finland
Sari Sireeni-Seirala – Fujitsu Finland Oy
Dr Olaf Queckenberg – Head of Global Chemical and Pharmaceutical Development, Bayer
Maarit Palo, Manager / Executive Government Affairs, IBM Finland, University Relations, IBM Nordic
Jyrki Lehtimäki, Senior Manager, Strategic Development, Biologics and New Modalities, Orion Corporation
Janne Lehtiranta, Senior Advisor, Turku Science Park Ltd.
Christer Nordstedt, Senior Vice President, Pharmaceutical Research and Development, Orion Corporation Orion Pharma

Finland is a leader in pharmaceutical research and research expertise

With an annual growth rate of more than 5 percent, health & well-being is the biggest industry in the world. Finland is a major player in the field, and its health technology exports, among other things, are significant on a global scale.

Facts about Finland:

  • Finland has the best availability of scientists and engineers in the world (World Economic Forum Competitiveness Index 2016-2017)
  • 3rd highest number of professionals working in research and development relative to the population (Bloomberg, Bloomberg 2017 Innovation Index)
  • The most stable country in the world (Fund of Peace, Fragile States Index 2016)
  • According to the 2017 Digital Economy and Society Index, Finland is the second most advanced digital economy in the EU

www.investinfinland.fi

Turku is a natural base for the Life Science Live event. The region boasts more than 100 companies, two medical and biotech-oriented universities and a leading research & development hub. More than 20 innovations from Turku have gained global prominence.
Life Science Live is not just an event, but also a bridge between research and business. It will offer information about the latest trends in science and business. A business matchmaking event is also being planned for the program.

Speakers at the event include Dipak Kalra, PhD, President of the European Institute for Health Records and of the European Institute for Innovation through Health Data; Laura Elo, PhD, Research Director in Bioinformatics and Group Leader in Computational Biomedicine (University of Turku and Åbo Akademi University); Moncef Gabbouj, PhD, Professor of Signal Processing; and Olli Raitakari, MD, PhD, Professor in Cardiovascular Medicine, Director of the Turku University Research Centre of Applied and Preventive Cardiovascular Medicine.

Health technology is one of the fastest-growing high-tech export fields in Finland. Finland is, in fact, one of seven countries in the world that export more health technology than they import.

−More than 80 per cent of the health technology products manufactured in Finland are exported. Companies still, however, need to develop their solutions in Finland together with research institutions and hospitals. This will help bring health technology solutions to patient care in Finland, promote companies’ growth and exports, and at the same time, lead to increased investments in Finland, explains Healthtech Finland’s CEO, Saara Hassinen.

Tickets and opening hours

Opening hours

  • 15.5.  9-17
  • 16.5.  9-18 (open for the general public 16-18)

Visitor registration will open Janyary 2019

 

General Delegate

One day online pass 150 € (ex. VAT)
  • Early bird 100 €, Onsite pass 180 €
  • Includes access to seminars, exhibition & partnering
Two days online pass 250 € (ex. VAT)
  • Early bird 180 €, Onsite pass 300 €
  • Includes access to seminars, exhibition & partnering
Full delegate / 2 day ticket + Get Together / online pass 320 € (ex. VAT)
  • Early bird 250 €, Onsite pass 400 €
  • Includes two day pass + Get Together
Additional tickets for Get Together 80 € / person (must bee booked in advance)  

Non-Profit Organizations – Small Companies

One day online pass 85 € (ex. VAT)
  • Early bird 40 €, Onsite pass 180 €
  • Includes access to seminars, exhibition & partnering
Two days online pass 150 € (ex. VAT)
  • Early bird 70 €, Onsite pass 300 €
  • Includes access to seminars, exhibition & partnering
Full delegate / 2 day ticket + Get Together / online pass 200 € (ex. VAT)
  • Early bird 130 €, Onsite pass 400 €
  • Includes two day pass + Get Together
Additional tickets for Get Together 80 € / person (must bee booked in advance)

 

 

 

15.05

16.05
2019

News

19.6.2018
Life Science Live
Finland to host international Life Science Live event

Life Science Live is a new international event for professionals in the fields of pharmaceuticals and healthcare. The event will take place at the Turku Fair an…

Read more